ArticleRadiology and oncology2025

Cardiotoxicity in low-to-moderate cardiovascular risk patients undergoing anti-HER2 therapy: a prospective cardiac magnetic resonance study.

Sainan Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.